Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Karuna Therapeutics Inc (NQ: KRTX ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Mar 15, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open - Bid (Size) 326.49 (1) Ask (Size) 329.94 (1) Prev. Close 329.83 Today's Range N/A - N/A 52wk Range 158.38 - 329.80 Shares Outstanding 37,443,954 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Beyond Tech And AI: Why The Sector Hedge Funds Prefer Is Not The One You'd Expect February 27, 2024 Hedge funds are shifting towards stability and value by favoring the health care sector over booming tech stocks. Via Benzinga Karuna Therapeutics: Q4 Earnings Insights February 22, 2024 Via Benzinga Performance More News Read More Karuna Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides General Business Update February 22, 2024 From Karuna Therapeutics, Inc. Via Business Wire Mental Health Mavericks: 3 Stocks Changing the Game February 21, 2024 Via InvestorPlace This Analyst Is Bullish On Biohaven's Approach in Neuro-Psych Space February 16, 2024 Via Benzinga Mizuho Downgrades Karuna Therapeutics: Here's What You Need To Know January 26, 2024 Via Benzinga KARUNA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Karuna Therapeutics, Inc. - KRTX February 14, 2024 From Kahn Swick & Foti, LLC Via Business Wire UBS Bullish On This Depression Drug Maker, Says Alzheimer's Agitation Data Is Attractive Catalyst February 06, 2024 Via Benzinga BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Catalent, Inc. (NYSE – CTLT), Everbridge, Inc. (Nasdaq – EVBG), Slam Corp. (Nasdaq – SLAM), Karuna Therapeutics, Inc. (Nasdaq – KRTX) February 05, 2024 From Brodsky & Smith LLC Via GlobeNewswire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AVROBIO, Inc. (Nasdaq – AVRO), California BanCorp (Nasdaq – CALB), Exro Technologies Inc. (OTC – EXROF), Karuna Therapeutics, Inc. (Nasdaq – KRTX) January 30, 2024 From Brodsky & Smith LLC Via GlobeNewswire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Karuna Therapeutics, Inc. (Nasdaq – KRTX), Carrols Restaurant Group, Inc. (Nasdaq - TAST), Ansys, Inc. (Nasdaq - ANSS), HomeStreet, Inc. (Nasdaq - HMST) January 26, 2024 From Brodsky & Smith LLC Via GlobeNewswire ABBV: This Top Biotech Just Went On A Buying Spree January 25, 2024 Via Talk Markets BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Karuna Therapeutics, Inc. (Nasdaq – KRTX), Carrols Restaurant Group, Inc. (Nasdaq - TAST), Ansys, Inc. (Nasdaq - ANSS), HomeStreet, Inc. (Nasdaq - HMST) January 22, 2024 From Brodsky & Smith LLC Via GlobeNewswire Bullish Continuation In '24? 3 Market Areas To Watch January 10, 2024 Via Talk Markets 5 Biotech Stocks That Should Be On Investors' Radar As JPMorgan Healthcare Conference Gets Underway Monday January 08, 2024 Via Benzinga Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024 January 05, 2024 Via Investor's Business Daily BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RayzeBio, Inc. (Nasdaq – RYZB), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Daseke, Inc. (Nasdaq – DSKE), Karuna Therapeutics, Inc. (Nasdaq – KRTX) January 04, 2024 From Brodsky & Smith LLC Via GlobeNewswire KARUNA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Karuna Therapeutics, Inc. - KRTX December 31, 2023 From Kahn Swick & Foti, LLC Via Business Wire Bristol Myers Squibb’s big buys: $18.1 billion in 2 biotech deals December 29, 2023 Via MarketBeat Stock Market Ending 2023 On High Note; Tesla, Drug M&A In Focus: Weekly Review December 29, 2023 Via Investor's Business Daily Topics Stocks Exposures US Equities Microsoft To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Thursday December 28, 2023 Via Benzinga BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RayzeBio, Inc. (Nasdaq – RYZB), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Daseke, Inc. (Nasdaq – DSKE), Karuna Therapeutics, Inc. (Nasdaq – KRTX) December 26, 2023 From Brodsky & Smith LLC Via GlobeNewswire Bristol-Myers' Acquisition Of Karuna Therapeutics Paves Way For Aggressive Global Marketing Of KarXT: Analyst December 26, 2023 Via Benzinga Bristol Myers' $4.1 Billion Deal For RayzeBio Sends RYZB Stock Soaring 100% December 26, 2023 Via Investor's Business Daily Why Is RayzeBio (RYZB) Stock Up 100% Today? December 26, 2023 Via InvestorPlace Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.